Your browser doesn't support javascript.
loading
Cost-Effectiveness of Initial Versus Delayed Lanreotide for Treatment of Metastatic Enteropancreatic Neuroendocrine Tumors.
Barnes, James I; Lin, John K; Gupta, Divya; Owens, Douglas K; Goldhaber-Fiebert, Jeremy D; Kunz, Pamela L.
Afiliación
  • Barnes JI; VA Palo Alto Health Care System, Palo Alto, California.
  • Lin JK; Center for Primary Care and Outcomes Research/Center for Health Policy, Department of Medicine, Stanford University School of Medicine, Stanford, California; and.
  • Gupta D; VA Palo Alto Health Care System, Palo Alto, California.
  • Owens DK; Center for Primary Care and Outcomes Research/Center for Health Policy, Department of Medicine, Stanford University School of Medicine, Stanford, California; and.
  • Goldhaber-Fiebert JD; Department of Medicine, Stanford University, Stanford, California; and.
  • Kunz PL; VA Palo Alto Health Care System, Palo Alto, California.
J Natl Compr Canc Netw ; 18(9): 1200-1209, 2020 09.
Article en En | MEDLINE | ID: mdl-32886901
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Péptidos Cíclicos / Somatostatina / Tumores Neuroendocrinos / Antineoplásicos Tipo de estudio: Clinical_trials / Guideline / Health_economic_evaluation / Prognostic_studies Límite: Humans Idioma: En Revista: J Natl Compr Canc Netw Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Péptidos Cíclicos / Somatostatina / Tumores Neuroendocrinos / Antineoplásicos Tipo de estudio: Clinical_trials / Guideline / Health_economic_evaluation / Prognostic_studies Límite: Humans Idioma: En Revista: J Natl Compr Canc Netw Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article